Author:
Kurian Joseph R.,Longlais Brett J.,Trepanier Lauren A.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics
Reference24 articles.
1. NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans;Kurian;J Pharmacol Exp Ther,2004
2. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis;Cribb;Adv Drug Reactions Toxicol Rev,1996
3. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5–b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1;Crofts;Carcinogenesis,1998
4. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl–DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation;Culp;Mutat Res,1997
5. The structure and biochemistry of NADH-dependent cytochrome b5 reductase are now consistent;Bewley;Biochemistry,2001
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献